Nuo Therapeutics, Inc.
AURXCIK 0001091596 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
242,500 bought / 240,100 sold
net +2,400 sh · −$1
- buys
- 3
- sells
- 3
- insiders active
- 3
Filing tape
Filed Thu, Jul 2, 2026
- ±0
Clausen Peter — CSO/COO
- Granted65,000Option to purchase common stock→ 65,000 held
- +1,608 sh · $1
Jorden David Emerson — CEO/CFO · Director
- Exercised162,500Common Stock@ $1.00→ 2,222,119 held
- Withheld for tax160,892Common Stock@ $1.01→ 2,061,227 held
- Exercised162,500Option to purchase common stock→ 0 held
- Granted125,000Option to purchase common stock→ 125,000 held
- +396 sh · $0
Pittman Scott M. — Director · 10% owner
- Exercised40,000Common Stock@ $1.00→ 5,440,000 held
- Withheld for tax39,604Common Stock@ $1.01→ 5,400,396 held
- Exercised40,000Option to purchase common stock→ 0 held
- Granted30,000Option to purchase common stock→ 30,000 held
- +396 sh · $0
Winzer C Eric — Director
- Exercised40,000Common Stock@ $1.00→ 212,654 held
- Withheld for tax39,604Common Stock@ $1.01→ 173,050 held
- Exercised40,000Option to purchase common stock→ 0 held
- Granted30,000Option to purchase common stock→ 30,000 held
- ±0
Mintz Paul — Director
- Granted30,000Option to Purchase Common Stock→ 30,000 held
Insiders on this tape
- Clausen PeterCSO/COO
- Jorden David EmersonCEO/CFO · Director
- Pittman Scott M.Director · 10% owner
- Winzer C EricDirector
- Mintz PaulDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.